- Home
- Publications
- Publication Search
- Publication Details
Title
Application of CRISPR/Cas9 in Alzheimer’s Disease
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 15, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-21
DOI
10.3389/fnins.2021.803894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Editing the immune system in vivo in mice using CRISPR/Cas9 ribonucleoprotein (RNP)-mediated gene editing of transplanted hematopoietic stem cells
- (2021) Rui Wang et al. METHODS
- CRISPR/Cas9-mediated CysLT1R deletion reverses synaptic failure, amyloidosis and cognitive impairment in APP/PS1 mice
- (2021) Fang Chen et al. Aging-US
- Arrayed CRISPR reveals genetic regulators of tau aggregation, autophagy and mitochondria in Alzheimer’s disease model
- (2021) Lishu Duan et al. Scientific Reports
- Base editing strategy for insertion of the A673T mutation in APP gene to prevent the development of Alzheimer's disease in vitro
- (2021) Antoine Guyon et al. Molecular Therapy-Nucleic Acids
- The CD33 short isoform is a gain-of-function variant that enhances Aβ1–42 phagocytosis in microglia
- (2021) Abhishek Bhattacherjee et al. Molecular Neurodegeneration
- Derivation of stem cell line UMi028-A-2 containing a CRISPR/Cas9 induced Alzheimer’s disease risk variant p.S1038C in the TTC3 gene
- (2021) Mayra Juliana Laverde-Paz et al. Stem Cell Research
- Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
- (2021) Chanchal Sharma et al. Antioxidants
- Dual and triple AAV delivery of large therapeutic gene sequences into the inner ear
- (2020) Omar Akil HEARING RESEARCH
- Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR–Cas9 plasmid
- (2020) Ami Jo et al. JOURNAL OF NANOBIOTECHNOLOGY
- Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies
- (2020) Henrik Zetterberg et al. MOLECULAR PSYCHIATRY
- Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
- (2020) Marta Milà‐Alomà et al. Alzheimers & Dementia
- Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
- (2020) You Lu et al. NATURE MEDICINE
- Depletion of the AD Risk Gene SORL1 Selectively Impairs Neuronal Endosomal Traffic Independent of Amyloidogenic APP Processing
- (2020) Allison Knupp et al. Cell Reports
- Alzheimer’s Disease risk modifier genes do not affect tau aggregate uptake, seeding or maintenance in cell models
- (2020) Sourav Kolay et al. FEBS Open Bio
- STIM1 Deficiency Leads to Specific Down-Regulation of ITPR3 in SH-SY5Y Cells
- (2020) Carlos Pascual-Caro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer’s disease
- (2020) Lutgarde Serneels et al. Molecular Neurodegeneration
- The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
- (2020) Mari Takalo et al. Molecular Neurodegeneration
- Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer’s disease
- (2020) Amanda McQuade et al. Nature Communications
- CRISPR/Cas9 Delivery Potentials in Alzheimer’s Disease Management: A Mini Review
- (2020) Amira Sayed Hanafy et al. Pharmaceutics
- Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
- (2020) Longfei Jia et al. Lancet Public Health
- Lipid nanoparticles loaded with ribonucleoprotein–oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition
- (2020) Yuichi Suzuki et al. JOURNAL OF CONTROLLED RELEASE
- Vascular dysfunction—The disregarded partner of Alzheimer's disease
- (2019) Melanie D. Sweeney et al. Alzheimers & Dementia
- Viral Delivery Systems for CRISPR
- (2019) Christine Xu et al. Viruses-Basel
- GSAP modulates γ-secretase specificity by inducing conformational change in PS1
- (2019) Eitan Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease
- (2019) Hanseul Park et al. NATURE NEUROSCIENCE
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease
- (2019) Anil R. Wadhwani et al. ANNALS OF NEUROLOGY
- Evaluation of CD33 as a genetic risk factor for Alzheimer’s disease
- (2019) Steven Estus et al. ACTA NEUROPATHOLOGICA
- Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities
- (2019) Judit M. Perez Ortiz et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Neuroprotection of KIBRA in Promoting Neuron Survival and Against Amyloid β-Induced Apoptosis
- (2019) Lin Song et al. Frontiers in Cellular Neuroscience
- Metal Ions in Alzheimer’s Disease: A Key Role or Not?
- (2019) Yan Liu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles
- (2019) Ji Liu et al. ADVANCED MATERIALS
- Correction to: STIM1 deficiency is linked to Alzheimer’s disease and triggers cell death in SH-SY5Y cells by upregulation of L-type voltage-operated Ca2+ entry
- (2019) Carlos Pascual-Caro et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Advance of sporadic Alzheimer's disease animal models
- (2019) Lili Zhang et al. MEDICINAL RESEARCH REVIEWS
- CRISPR-Cas9 system: A new-fangled dawn in gene editing
- (2019) Darshana Gupta et al. LIFE SCIENCES
- The Microbiota-Gut-Brain Axis
- (2019) John F. Cryan et al. PHYSIOLOGICAL REVIEWS
- Upregulation of Thioredoxin-Interacting Protein in Brain of Amyloid-β Protein Precursor/Presenilin 1 Transgenic Mice and Amyloid-β Treated Neuronal Cells
- (2019) Yiran Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Recent advances in CRISPR/Cas9-mediated knock-ins in mammalian cells
- (2019) Mehdi Banan JOURNAL OF BIOTECHNOLOGY
- Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening
- (2019) Pedro P.G. Guimaraes et al. JOURNAL OF CONTROLLED RELEASE
- Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy
- (2018) Peng Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- SaCas9 Requires 5′-NNGRRT-3′ PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human Cells
- (2018) Haihua Xie et al. Biotechnology Journal
- Delivering CRISPR: a review of the challenges and approaches
- (2018) Christopher A. Lino et al. DRUG DELIVERY
- Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells
- (2018) Akiko Seki et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clinical use of lentiviral vectors
- (2018) Michael C. Milone et al. LEUKEMIA
- Targeted Gene Editing of Glia Maturation Factor in Microglia: a Novel Alzheimer’s Disease Therapeutic Target
- (2018) Sudhanshu P. Raikwar et al. MOLECULAR NEUROBIOLOGY
- The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease
- (2018) Paul J. Cheng-Hathaway et al. Molecular Neurodegeneration
- Triple Vectors Expand AAV Transfer Capacity in the Retina
- (2018) Andrea Maddalena et al. MOLECULAR THERAPY
- Genetic screening in two Iranian families with early-onset Alzheimer's disease identified a novel PSEN1 mutation
- (2018) Jen-Chyong Wang et al. NEUROBIOLOGY OF AGING
- APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types
- (2018) Yuan-Ta Lin et al. NEURON
- Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
- (2018) Alexis A. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Generation of App knock-in mice reveals deletion mutations protective against Alzheimer’s disease-like pathology
- (2018) Kenichi Nagata et al. Nature Communications
- SaCas9 Requires 5′-NNGRRT-3′ PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human Cells
- (2018) Haihua Xie et al. Biotechnology Journal
- Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
- (2018) Vo Van Giau et al. Clinical Interventions in Aging
- CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease
- (2018) Bence György et al. Molecular Therapy-Nucleic Acids
- Clinical Phenotype of G206D Mutation in the Presenilin 1 Gene in Pathologically Confirmed Familial Alzheimer's Disease
- (2018) Ya-Ying Wu et al. JOURNAL OF ALZHEIMERS DISEASE
- GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
- (2018) Rosalie M. Sterner et al. BLOOD
- CRISPR-Cas9 in genome editing: Its function and medical applications
- (2018) Saedeh Khadempar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements
- (2018) Annalisa Lattanzi et al. MOLECULAR THERAPY
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage
- (2018) Jichao Sun et al. Nature Communications
- Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer’s Disease
- (2018) Christy O.Y. Hung et al. Cell Reports
- Nonintegrating Gene Therapy Vectors
- (2017) Takis Athanasopoulos et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
- (2017) Eric Tönnies et al. JOURNAL OF ALZHEIMERS DISEASE
- Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer’s Disease Brain
- (2017) Mohammad Ejaz Ahmed et al. JOURNAL OF ALZHEIMERS DISEASE
- Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
- (2017) Chang Liu et al. JOURNAL OF CONTROLLED RELEASE
- Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
- (2017) Hao Yin et al. NATURE BIOTECHNOLOGY
- CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2 N141I neurons
- (2017) Maitane Ortiz-Virumbrales et al. Acta Neuropathologica Communications
- Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice
- (2016) Ling Li et al. ACS Nano
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- CRISPR-Cas9 technology: applications and human disease modelling
- (2016) Raul Torres-Ruiz et al. Briefings in Functional Genomics
- Programmable RNA Tracking in Live Cells with CRISPR/Cas9
- (2016) David A. Nelles et al. CELL
- Gene editing for cell engineering: trends and applications
- (2016) Sanjeev K. Gupta et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer
- (2016) William J. Marks et al. HUMAN GENE THERAPY
- Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes
- (2016) Sean Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
- (2016) Dominik Paquet et al. NATURE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- Diabetes and Alzheimer’s disease crosstalk
- (2016) David Baglietto-Vargas et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase
- (2016) Linfeng Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Inducible in vivo genome editing with CRISPR-Cas9
- (2015) Lukas E Dow et al. NATURE BIOTECHNOLOGY
- A split-Cas9 architecture for inducible genome editing and transcription modulation
- (2015) Bernd Zetsche et al. NATURE BIOTECHNOLOGY
- Efficient CRISPR-rAAV engineering of endogenous genes to study protein function by allele-specific RNAi
- (2015) Manuel Kaulich et al. NUCLEIC ACIDS RESEARCH
- Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
- (2015) Kathrin Schumann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- Immunological data from cancer patients treated with Ad5/3 E2F Δ24 GMCSF suggests utility for tumor immunotherapy
- (2015) Otto Hemminki et al. Oncotarget
- A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
- (2014) Michael S. Rafii et al. Alzheimers & Dementia
- Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos
- (2014) Yuyu Niu et al. CELL
- Germline acquisition of Cas9/RNA-mediated gene modifications in monkeys
- (2014) Yongchang Chen et al. CELL RESEARCH
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Understanding the cause of sporadic Alzheimer’s disease
- (2014) Henrik Zetterberg et al. Expert Review of Neurotherapeutics
- Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
- (2014) Svend O. Freytag et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Chitooligosaccharides Attenuate Cu2+-Induced Cellular Oxidative Damage and Cell Apoptosis Involving Nrf2 Activation
- (2014) Han-Chang Huang et al. NEUROTOXICITY RESEARCH
- The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications
- (2014) Cristian Capasso et al. Viruses-Basel
- One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering
- (2013) Hui Yang et al. CELL
- A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
- (2013) Kenneth H. Kim et al. GYNECOLOGIC ONCOLOGY
- Comparative Analysis of Adeno-Associated Virus Capsid Stability and Dynamics
- (2013) V. Rayaprolu et al. JOURNAL OF VIROLOGY
- RNA-guided editing of bacterial genomes using CRISPR-Cas systems
- (2013) Wenyan Jiang et al. NATURE BIOTECHNOLOGY
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
- (2013) Ana Griciuc et al. NEURON
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
- (2012) Lucía Chávez-Gutiérrez et al. EMBO JOURNAL
- A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
- (2012) James M. Burke et al. JOURNAL OF UROLOGY
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
- (2012) G. Gasiunas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Antiasthmatic Drugs Targeting the Cysteinyl Leukotriene Receptor 1 Alleviate Central Nervous System Inflammatory Cell Infiltration and Pathogenesis of Experimental Autoimmune Encephalomyelitis
- (2011) L. Wang et al. JOURNAL OF IMMUNOLOGY
- The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
- (2010) Michael R. Lieber Annual Review of Biochemistry
- Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
- (2010) David Escors et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease
- (2010) Gen He et al. NATURE
- Manufacturing and characterizing AAV-based vectors for use in clinical studies
- (2008) J F Wright GENE THERAPY
- Transgene Expression, Bioactivity, and Safety of CERE-120 (AAV2-Neurturin) Following Delivery to the Monkey Striatum
- (2008) Christopher D Herzog et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now